Last10K.com

Gala Pharmaceutical Inc. (GLPH) SEC Filing 10-Q Quarterly report for the period ending Friday, August 31, 2018

Gala Pharmaceutical Inc.

CIK: 1513403 Ticker: GLPH
Document and Entity Information - shares
9 Months Ended
Aug. 31, 2018
Oct. 22, 2018
Document And Entity Information  
Entity Registrant NameGala Pharmaceutical Inc. 
Entity Central Index Key0001513403 
Document Type10-Q 
Document Period End DateAug. 31, 2018 
Amendment Flagfalse 
Current Fiscal Year End Date--11-30 
Is Entity's Reporting Status Current?Yes 
Is Entity Emerging Growth Company?false 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Businesstrue 
Entity Ex Transition Periodfalse 
Entity Common Stock, Shares Outstanding 78,954,937
Document Fiscal Period FocusQ3 
Document Fiscal Year Focus2018 

View differences made from one quarter to another to evaluate Gala Pharmaceutical Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Gala Pharmaceutical Inc..

Continue

Assess how Gala Pharmaceutical Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Gala Pharmaceutical Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Condensed Consolidated Balance Sheets (Unaudited)
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)
Condensed Consolidated Statements Of Cash Flows (Unaudited)
Condensed Consolidated Statements Of Operations (Unaudited)
1. Organization And Nature Of Operations
1. Organization And Nature Of Operations (Details Narrative)
10. Common Shares
10. Common Shares (Details Narrative)
11. Share Purchase Warrants
11. Share Purchase Warrants (Details Narrative)
11. Share Purchase Warrants (Details)
11. Share Purchase Warrants (Tables)
12. Commitment
12. Commitment (Details Narrative)
12. Commitment (Details)
12. Commitment (Tables)
13. Contingency
14. Supplemental Disclosures
14. Supplemental Disclosures (Details)
14. Supplemental Disclosures (Tables)
15. Subsequent Events
2. Summary Of Significant Accounting Policies
2. Summary Of Significant Accounting Policies (Details - Fair Value Of Derivatives)
2. Summary Of Significant Accounting Policies (Details Narrative)
2. Summary Of Significant Accounting Policies (Policies)
3. Sale Of Subsidiaries
3. Sale Of Subsidiaries (Details Narrative)
4. Deferred Compensation
4. Deferred Compensation (Details Narrative)
5. Equipment
5. Equipment (Details Narrative)
5. Equipment (Details)
5. Equipment (Tables)
6. Convertible Debenture
6. Convertible Debenture (Details Narrative)
7. Derivative Liability
7. Derivative Liability (Details - Assumptions)
7. Derivative Liability (Details - Fair Value)
7. Derivative Liability (Details Narrative)
7. Derivative Liability (Tables)
8. Related Party Transactions
8. Related Party Transations (Details Narrative)
9. Loans Payable
9. Loans Payable (Details Narrative)

Material Contracts, Statements, Certifications & more

Gala Pharmaceutical Inc. provided additional information to their SEC Filing as exhibits

Ticker: GLPH
CIK: 1513403
Form Type: 10-Q Quarterly Report
Accession Number: 0001683168-18-003151
Submitted to the SEC: Thu Oct 25 2018 5:37:51 PM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Friday, August 31, 2018
Industry: Apparel And Other Finishd Prods Of Fabrics And Similar Matl

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/glph/0001683168-18-003151.htm